If you bought Infants’ Tylenol over the past five years you may be eligible to claim part of a $6.3 million settlement.
The plaintiffs in the class action lawsuit claim that the packaging is misleading, deceiving customers into believing Infants’ Tylenol is specially formulated for babies when it actually contains liquid acetaminophen of the same concentration as Children’s Tylenol. As a result, the lawsuit claims parents overpaid for the medication.
You’re eligible for the settlement if you bought the product between Oct. 3, 2014, and Jan. 6, 2020. You must file a claim by April 13, 2020. Learn more at this website.
Johnson & Johnson Consumer Inc. denies the allegations of deception and believes the two medications—Infants’ Tylenol and Children’s Tylenol—are distinct products. The company points to additional safety features included with Infants’ Tylenol, such as a dosage syringe.
The company has set up a settlement fund of up to $6.315 million. A maximum of seven bottles or $15.05 may be claimed without a proof of purchase; an unlimited number of bottles may be claimed with proof of purchase.
As part of the settlement, Johnson & Johnson will also make “reasonably diligent efforts” to modify the packaging of both products to make it clear that the liquid medicine in Infants’ Tylenol and Children’s Tylenol has the same concentration of acetaminophen.
- St. Paul’s beats Pleasant Grove to win 5A State Championship
- U.S. House passes bill that would prohibit public contact with big cats, like tigers
- More than 25 people rescued from human smuggling operation in Texas
- USA Health reports COVID-19 testing up 20 percent since Thanksgiving
- Comedian documenting fight against COVID-19 dies after 2nd Instagram video